Phase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+

NCT01755325 · clinicaltrials.gov ↗

PHASE3

Phase

SUSPENDED

Status

680

Enrollment

OTHER

Sponsor class

Stopped not enough patients

Conditions

Chronic Myelogenous Leukemia

Interventions

DRUG: Compound realgar natural indigo Tablet
DRUG: placebo

Sponsor

Junmin Li